Citrate anticoagulation: Are blood donors donating bone?

Area of Science:

• * Blood banking and transfusion medicine
• * Physiology and toxicology

Background:

• * Apheresis blood donation procedures are increasing, with citrate used for anticoagulation.
• * Citrate exposure causes an acute physiological response in donors.
• * Concerns exist regarding potential long-term health effects, particularly on bone mineral density, due to repeated citrate exposure.

Purpose of the Study:

• * To review the acute physiological response to citrate anticoagulation in apheresis donors.
• * To present differing viewpoints on citrate's potential effects on bone density.
• * To identify knowledge gaps concerning long-term health outcomes in regular apheresis donors.

Main Methods:

• * Literature review of existing research on citrate anticoagulation and its physiological effects.
• * Analysis of current data on short-term and potential long-term sequelae of citrate exposure.
• * Identification of areas requiring further investigation into donor health.

Main Results:

• * Citrate anticoagulation is standard in apheresis, leading to acute donor responses.
• * Data on short-term effects of citrate are available, but long-term outcomes remain less understood.
• * Contrasting perspectives exist regarding citrate's impact on bone mineral density.

Conclusions:

• * The long-term health implications of repeated citrate exposure in apheresis donors require further study.
• * Key knowledge gaps exist in understanding the chronic effects of citrate on donor health, particularly bone health.
• * Additional research is needed to address donor safety concerns associated with frequent apheresis procedures.